Endothelial cell type | Plasmodium strain | Evaluated parameters | Endothelial phenotype | Ref. |
---|---|---|---|---|
Porcine brain capillary endothelial cells (PBCEC) | P. falciparum | - ICAM-1, E-selectin expression; | - increased ICAM-1 and E-selectin | [99] |
- TEER; | - decreased BBB function; | |||
- tight junction expression | - tight junction disruption | |||
Human umbilical vascular endothelial cells (HUVEC) co-cultured with iRBC-fed peripheral blood mononuclear cells | P. falciparum from patients with uncomplicated malaria, severe malaria, or CM | mRNA expression of: | - increased adhesion molecule mRNA (not CM-specific); | [100] |
- adhesion molecules (ICAM-1, VCAM-1, E-selectin); | ||||
- reduced tight junction mRNA (CM-specific) | ||||
- tight junctions (occludin, vinculin, ZO-1) | ||||
TNF-α- or LT-α-activated human brain endothelial cell line (HBEC-5i) (with/without platelet co-culture) | P. falciparum | - permeability to 70-kDa dextran; | - increased BBB permeability; | [101] |
- TEER; | - decreased BBB function; | |||
- endothelial microparticle release; | - increased microparticle release; | |||
- endothelial apoptosis | - increased endothelial apoptosis (all effects potentiated by platelets) | |||
Human brain microvascular endothelial cells (HBMEC); HUVEC | P. falciparum | - ICAM-1 expression | increased ICAM-1 expression in HBMEC but not in HUVEC | [93] |
HBMEC | P. falciparum | - electrical cell substrate sensing; | - reduced BBB function; | [102] |
- TEER | - increased BBB permeability | |||
Human dermal microvascular endothelial cells (HDMEC); human lung microvascular endothelial cells (HLMEC) (with parasite sonicates or iRBCs) | P. falciparum | - immunofluorescence staining of ZO-1, claudin-5, VE-cadherin; | - loss in total protein content of claudin-5; | [103] |
- observation of inter-endothelial gaps in monolayers; | - redistribution of ZO-1 from cytoskeleton to membrane and cytosolic/nuclear fractions; | |||
- evaluation of pro-inflammatory response, direct cellular cytotoxicity or cell death. | ||||
- minimal inflammation and death (all effects only with sonicates) | ||||
HBMEC | P. falciparum | - expression of transcriptome (including ICAM-1 and pro-inflammatory molecules) | - increased expression of ICAM-1 and pro-inflammatory molecules | [104] |
HBEC-5i; immortalized human cerebral microvascular cell line hCMEC/D3 | P. falciparum | - immunofluorescent microscopy to evaluate malaria antigen presentation by endothelial cells; | - malaria antigen presentation by endothelial cells; | [56] |
- tight junction opening; | ||||
- TEER | - increased BBB permeability | |||
hCMEC/D3 | P. falciparum | - fluorescent permeability assay; | - increased BBB permeability; | [105] |
- expression of cell adhesion molecules and tight junctions | - increased ICAM-1 expression; | |||
- cytoadherence; | ||||
- altered ZO-1 distribution | ||||
TNF-α-activated subcutaneous fat tissue-derived EC from patients with uncomplicated malaria or CM | P. falciparum | - adhesion molecule expression (ICAM-1, VCAM-1, CD61, CD62-E) | - higher ICAM-1, VCAM-1, CD61; | [106] |
- enhanced microparticle release; | ||||
- microparticle production; | ||||
- induced MCP-1 and IL-6 release; | ||||
- MCP-1, RANTES, IL-6 release ; | - higher caspase-3 activation (all effects CM-specific) | |||
- caspase-3 activation | ||||
HBEC-5i | P. falciparum (various strains) | parasite strain selection assay based on cytoadherence | CM-associated cytoadherence | [107] |
Murine brain vascular endothelial cells (MBVEC) murine lung vascular endothelial cells (MLVEC) | P. berghei ANKA (CM model); P. berghei K173 (non-CM model) | - study of cytoadherence mechanisms; | higher VCAM-1-mediated cytoadherence in CM model compared to non-CM model | [108] |